不同干预模式对急性冠脉综合征患者二级预防治疗依从性的影响
结果显示护士宣教和联合干预可提高部分药物依从性,联合干预效果更优,但宣传台历组和宣教组再住院率高于对照组。
要点
- 护士宣教可提高ACS患者抗血小板药物和他汀类药物依从性。
- 联合干预可进一步提高他汀、ACEI/ARB及四药联合使用率。
- 宣传台历组和宣教组因ACS再住院率高于对照组。
核心结论
- 护士宣教和发放宣传台历均可提高ACS患者出院后二级预防药物依从性,护士宣教优于单纯发放台历,联合干预效果更佳。
主要发现
- 出院6个月,宣传教育组抗血小板药物使用率97.0%(526/542)、他汀类药物使用率91.0%(493/542),分别较对照组高3.7%和5.5%(P均<0.016)。
- 联合干预组他汀类药物使用率91.0%(496/545)、ACEI/ARB使用率68.3%(372/545)、四药联合使用率53.2%(290/545),分别较对照组高5.5%、8.3%和9.6%(P均<0.016)。
- Poisson回归显示联合干预组ACEI/ARB使用率较对照组、宣传台历组和宣传教育组分别高15.4%(OR=1.154,95%CI 1.057~1.259)、20.0%(OR=1.200,95%CI 1.096~1.314)和25.5%(OR=1.255,95%CI 1.142~1.380)(P均<0.01)。
- 联合干预组四药联合使用率较对照组、宣传台历组和宣传教育组分别高21.6%(OR=1.216,95%CI 1.079~1.371)、21.5%(OR=1.215,95%CI 1.077~1.371)和27.8%(OR=1.278,95%CI 1.126~1.450)(P均<0.01)。
- 宣传教育组和联合干预组血压控制率分别高于对照组和宣传台历组(P均<0.016);宣传台历组和宣传教育组再住院率分别为7.0%(39/561)和7.6%(42/561),高于对照组3.8%(21/561)(P均<0.016)。
关键数值与推荐
- 血压控制定义为<140/90 mmHg(1 mmHg=0.133 kPa)。
- 低密度脂蛋白胆固醇控制目标为<2.07 mmol/L。
- 统计显著性阈值采用P<0.016(多重比较校正)。
临床怎么用
- 对ACS住院患者可采用护士宣教或发放宣传台历提高出院后二级预防药物依从性。
- 护士宣教效果优于单纯发放宣传台历,两者联合可进一步改善依从性。
局限性
- 为横断面研究,虽经倾向性评分匹配,仍可能存在未测量混杂。
- 宣传台历组和宣教组再住院率高于对照组,需进一步研究解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome (ACS). Methods: This multi-center cross-sectional study collected data from 34 hospitals covering 22 provinces in China. Hospitals were randomly divided into four groups: control group(routine treatment and care), promotional calendar group (routine treatment and care plus giving propaganda desk calendar to patients), education group (routine treatment and care add patients education by nurses) and combined intervention group (promotional calendar and education).At least 90 patients with ACS were consecutively enrolled from each involved hospital from April 15, 2012 to June 30, 2013. To reduce the impact of uneven distribution of inter-group variables on the results, 1∶1∶1∶1 propensity score matching method was used. The drug usage for secondary prevention and prognosis wasobtainedat 6 months after hospital discharge. Results: (1) A total of 3 391 patients were selected and 2 244 patients were included for the final analysisafter propensity score analysis. (2) At 6 months after discharge, the adherence rates of antiplatelet, statins, angiotensin converting enzyme inhibitor(ACEI)/angiotensin Ⅱ receptor blocker(ARB), β-blocker and the combination of 4 medications were similar between control group and promotional calendar group (all P>0.016).The adherence rates of antiplatelet and statins were 97.0% (526/542) and 91.0% (493/542) in the education group, 3.7% and 5.5% higher than in the control group (both P<0.016). The adherence rates of statins,ACEI/ARB and combined medication were 91.0% (496/545), 68.3% (372/545) and 53.2% (290/545) in the combined intervention group,significantly higher than in the control group (5.5%,8.3% and 9.6%, all P<0.016). (3) Poisson regression analysis showed that the adherence of antiplatelet drugs in the education group was 3.4%(OR=1.034, 95%CI 1.007-1.060,P<0.05) and 3.5%(OR=1.035, 95%CI 1.007-1.063, P<0.05) higher than in the control group and the promotional calendar group, and the statins adherence rate was 5.5%(OR=1.055, 95%CI 1.012-1.101,P<0.05) higher than in the control group. The antiplatelet drug adherence rates in the combined intervention group were 3.0% (OR=1.030, 95%CI 1.002-1.058,P<0.05) and 3.1% (OR=1.031, 95%CI 1.003-1.060,P<0.05) higher than in the control group and the promotional calendar group, respectively, and statin adherence was 6.1% (OR=1.061, 95%CI 1.017-1.107,P<0.01) higher than in the control group. The adherence rates of ACEI/ARB in combined intervention group were respectively 15.4%(OR=1.154, 95%CI 1.057-1.259, P<0.01),20.0%(OR=1.200, 95%CI 1.096-1.314, P<0.01) and 25.5%(OR=1.255, 95%CI 1.142-1.380, P<0.01) higher than in the control group, promotional calendar group and education group. The adherence rates of combined medication in combined intervention group were respectively 21.6%(OR=1.216, 95%CI 1.079-1.371, P<0.01),21.5%(OR=1.215, 95%CI 1.077-1.371, P<0.01) and 27.8%(OR=1.278, 95%CI 1.126-1.450, P<0.01) higher than in the control group, promotional calendar group and education group. (4) At 6 months after discharge, the control rates of blood pressure (<140/90 mmHg,1 mmHg=0.133 kPa) in the education group were significantly higher than in the control group and promotional calendar group (78.7% (398/506) vs. 70.2%(373/531) and 71.1% (354/498) , all P<0.016),and the control rates of blood pressure in combined intervention group were higher than in the control group and promotional calendar group (78.2% (376/481) vs. 70.2%(373/531) and 71.1% (354/498) , all P<0.016).The rehospitalization rates were 7.0% (39/561) in the promotional calendar group, and 7.6% (42/561) in the education group, both significantly higher than in the control group (3.8% (21/561), all P<0.016).The rate of the low density lipoprotein cholesterol<2.07 mmol/L and the rate for all-cause mortality were similar among groups (all P>0.016) . Conclusion: Post-discharge medication adherence in ACS patients can be enhanced by either promotional calendaror nurses education strategy, and the efficacy is better by nurse education as compared with promotional calendar, the combination of both methods can further increase the post-discharge medication adherence rates in ACS patients. 目的: 分析不同干预模式对急性冠状动脉综合征(ACS)患者二级预防药物依从性的影响。 方法: 采用整群随机分组方法,将全国22个省、自治区和直辖市的34家协作医院按1∶1的比例分为4组,即对照组(常规治疗和护理)、宣传台历组(在常规治疗基础上,向患者发放宣传台历)、宣传教育组(在常规治疗基础上,护士对患者进行宣教)和联合干预组(在常规治疗基础上,向患者发放宣传台历,并由护士对患者进行宣教)。从2012年4月15日至2013年6月30日,各协作医院均连续纳入符合标准的住院ACS患者≥90例。为使4组ACS患者的基线特点分布均衡,采用倾向性评分方法,对组间样本进行1∶1∶1∶1匹配。分别在出院后3和6个月对患者进行随访,调查二级预防药物使用及预后情况。 结果: (1)各协作医院共收集ACS患者3 391例,倾向性评分后最终纳入分析的患者共2 244例。(2)出院后6个月,宣传台历组与对照组之间的抗血小板药物、他汀类药物、血管紧张素转换酶抑制剂(ACEI)或血管紧张素Ⅱ受体拮抗剂(ARB)、β受体阻滞剂及4类药物联合使用率差异均无统计学意义(P均>0.016);宣传教育组抗血小板药物使用率为97.0%(526/542)、他汀类药物使用率为91.0%(493/542),分别较对照组高3.7%和5.5%(P均<0.016);联合干预组他汀类药物使用率为91.0%(496/545),ACEI/ARB使用率为68.3%(372/545),4类药物联合使用率为53.2%(290/545),分别较对照组高5.5%、8.3%和9.6%(P均<0.016)。(3)Poisson回归分析显示,出院后6个月,宣传教育组抗血小板药物使用率分别比对照组和宣传台历组高3.4%(OR=1.034,95%CI 1.007~1.060,P<0.05)和3.5%(OR=1.035,95%CI 1.007~1.063,P<0.05),他汀类药物使用率比对照组高5.5%(OR=1.055,95%CI 1.012~1.101,P<0.05);联合干预组抗血小板药物使用率分别比对照组和宣传台历组高3.0%(OR=1.030,95%CI 1.002~1.058,P<0.05)和3.1%(OR=1.031,95%CI 1.003~1.060,P<0.05),他汀类药物使用率比对照组高6.1%(OR=1.061,95%CI 1.017~1.107,P<0.01),ACEI/ARB药物使用率分别比对照组、宣传台历组和宣传教育组高15.4%(OR=1.154,95%CI 1.057~1.259,P<0.01)、20.0%(OR=1.200,95%CI 1.096~1.314,P<0.01)和25.5%(OR=1.255,95%CI 1.142~1.380,P<0.01),4类药物联合使用率分别比对照组、宣传台历组和宣传教育组高21.6%(OR=1.216,95%CI 1.079~1.371,P<0.01)、21.5%(OR=1.215,95%CI 1.077~1.371,P<0.01)和27.8%(OR=1.278,95%CI 1.126~1.450,P<0.01)。(4)出院后6个月,宣传教育组血压控制(血压<140/90 mmHg,1 mmHg=0.133 kPa)率分别高于对照组和宣传台历组[78.7%(398/506)比70.2%(373/531)和71.1%(354/498),P均<0.016],联合干预组血压控制率分别高于对照组和宣传台历组[78.2%(376/481)比70.2%(373/531)和71.1%(354/498),P均<0.016];宣传台历组和宣传教育组因ACS再住院率均高于对照组[7.0%(39/561)和7.6%(42/561)比3.8%(21/561),P均<0.016];4组之间的低密度脂蛋白胆固醇<2.07 mmol/L和全因死亡比率差异均无统计学意义(P均>0.016)。 结论: 对住院ACS患者采用护士宣教和发放宣传台历可提高患者出院后的二级预防药物依从性,单纯护士宣教比单纯发放宣传台历的效果好,而两种干预方法联合可以进一步提高效果。.
引用
- Liu J, Wang W, Liu J, et al. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 29495236. doi:10.3760/cma.j.issn.0253-3758.2018.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。